Emerging trends in synthesis, characterization, and mechanism of action of antibody-drug and antibody-nanoparticle conjugates
Abstract Antibody-drug conjugates (ADCs) and antibody-conjugated nanoparticles (ACNPs) are targeted therapies achieved by combining monoclonal antibodies (mAbs) with cytotoxic payloads or nanocarriers. ADCs consist of mAbs conjugated to the cytotoxic payloads via a linker, thus enabling tumor-specif...
Saved in:
| Main Authors: | Tanu Dixit, Annamraju Aswini, Harshal Nikam, Anuradha Vaidya, Selvan Ravindran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-08-01
|
| Series: | Discover Nano |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s11671-025-04303-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management
by: Tanu Dixit, et al.
Published: (2025-12-01) -
Interrogating heterogeneity of cysteine-engineered antibody-drug conjugates and antibody-oligonucleotide conjugates by capillary zone electrophoresis-mass spectrometry
by: Tian Xu, et al.
Published: (2023-12-01) -
The Impact of Conjugation Mode and Site on Tubulysin Antibody‐Drug‐Conjugate Efficacy and Stability
by: Sayumi Yamazoe, et al.
Published: (2025-08-01) -
Editorial: Antibody-drug conjugates in solid and hematologic malignancies
by: Khalil Saleh, et al.
Published: (2025-08-01) -
Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
by: Isis Wolf, et al.
Published: (2025-01-01)